West Lafayette, IN, United States of America

Stanley L Hem

This inventor holds 5 USPTO granted patents. Top assignee: Purdue Research Foundation. Active years: 1977-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stanley L Hem. Retrieved from https://idiyas.com/inventor/stanley-l-hem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1977-2018

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Stanley L Hem

Introduction

Stanley L Hem is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of immunology, holding a total of 5 patents. His work primarily focuses on developing immunogenic compositions and reagents that enhance vaccine efficacy and immune responses.

Latest Patents

Among his latest patents, Stanley has developed immunogenic compositions and reagents for preparing compounds and conjugates. The inventions described in these patents pertain to various compositions, complexes, and formulations that include these compounds and/or conjugates. They also detail methods of using these innovations in vaccines and vaccinations to generate robust immune responses.

Career Highlights

Stanley L Hem is affiliated with the Purdue Research Foundation, where he continues to advance research in immunology. His work has been instrumental in the development of new vaccine technologies that aim to improve public health outcomes.

Collaborations

Stanley has collaborated with esteemed colleagues such as Harm Hogenesch and Irene A George. These partnerships have fostered a collaborative environment that enhances the research and development of innovative immunological solutions.

Conclusion

Stanley L Hem's contributions to immunology through his patents and collaborations highlight his commitment to advancing vaccine technology. His work continues to impact the field positively, paving the way for future innovations in immunogenic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…